Compare Agilent Technologies Inc (A) vs Las Vegas Sands Corp. (LVS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs Las Vegas Sands Corp. — how do they compare? Agilent Technologies Inc trades at $128.5 (market cap $37.04B), while Las Vegas Sands Corp. trades at $46.14 (market cap $30.52B). The key difference: Agilent Technologies Inc is the larger of the two by market cap, and Las Vegas Sands Corp. pays the higher dividend (2.39%). Which is the better fit depends on your goals.
| A | LVS | |
|---|---|---|
Market Cap | $37.04B | $30.52B |
Sector | Health | Consumer Cyclical |
52-Week High | $157.20 | $69.49 |
52-Week Low | $110.24 | $46.06 |
Enterprise Value | $38.59B | $42.92B |
Dividend Yield | 0.78% | 2.39% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
LVS trades at $46.06, down 1.98% on the day, amid a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.91 exceeding expectations, and maintains robust profitability with a net income margin of 13.41%. Recent news highlights ESG achievements and Macao's economic diversification efforts. Cash flow trends show positive net cash flow in 2025 after previous years of outflows.
The outlook for LVS is supported by solid fundamentals and analyst optimism, with a consensus price target of $66.38 implying significant upside. Risks include high debt levels, with a debt-to-asset ratio of 73.15% in 2025, and exposure to Macao's regulatory environment. Institutional sentiment remains positive, with no sell ratings among 49 analysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Las Vegas Sands Corp.
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner, Four Seasons Hotel Macao, and Parisian in Macao, and the Marina Bay Sands resort in Singapore. Its Venetian and Palazzo Las Vegas in the U.S. asets were sold to Apollo and VICI for $6.25 billion in 2022. We expect Sands to open a fourth tower in Singapore in 2026. After the sale of its Vegas assets, the company will generate all its EBITDA from Asia, with its casino operations generating the majority of sales.
Read more on LVS →
